Abstract
Disseminated intravascular coagulation (DIC) is a complex acquired, coagulopathy resulting from excessive thrombin formation. Abnormal tissue factor (TF) expression is a major mechanism initiating DIC in many disorders, including obstetric complications, sepsis, cancer, and trauma. Numerous laboratory tests are available to monitor DIC, but most patients can be adequately managed using only routine hemostasis screening tests, and assays for fibrinogen and D-dimers. Treatment of DIC should focus on reversing the underlying disorder that initiated the coagulopathy. Novel treatments are being investigated for the treatment of DIC; many of these experimental modalities target the excessive TF activity that characterizes DIC.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Wuillemin W. (1997) Activation of the contact system in patients with sepsis and with septic. Blood 89(10), 3893.
Pixley R., Cadena R. D. L., Page J., Kaufman N., Wyshock E., Chang A., Taylor F., and Colman R. (1993) The contact system contributes to hypotension but not disseminated intravascular coagulation in lethal bacteremia. J. Clin. Invest. 91, 61–68.
Broze G. J., Jr. (1995) Tissue factor pathway inhibitor and the revised theory of coagulation. Annu. Rev. Med. 46, 103–112.
Luchtman-Jones L. and Broze G. J. Jr. (1995) The current status of coagulation. Ann. Med. 27(1), 47–52.
Muller-Berghaus G., ten Cate H., and Levi M. (1999) Disseminated intravascular coagulation: clinical spectrum and established as well as new diagnostic approaches. Thromb. Haemost. 82(2), 706–712.
Wada H., Wakita Y., Nakase T., Shimura M., Hiyoyama K., Nagaya S., Mori Y., and Shiku H. (1995) Outcome of disseminated intravascular coagulation in relation to the score when treatment was begun. Mie DIC Study Group. Thromb. Haemost. 74(3), 848–852.
Brandtzaeg P., Sandset P. M., Joo G. B., Ovstebo R., Abildgaard U., and Kierulf P. (1989) The quantitative association of plasma endotoxin, antithrom-bin, protein C, extrinsic pathway inhibitor and fibrinopeptide A in systemic men-ingococcal disease. Thromb. Res. 55(4), 459–470.
Fourrier F., Lestavel P., Chopin C., Marey A., Goudemand J., Rime A., and Mangalaboyi J. (1990) Meningococcemia and purpura fulminans in adults: acute deficiencies of proteins C and S and early treatment with antithrombin III concentrates. Intensive Care Med. 16(2), 121–124.
Fourrier F., Chopin C., Goudemand J., Hendrycx S., Caron C., Rime A., et al. (1992) Septic shock, multiple organ failure, and disseminated intravascular coagulation. Compared patterns of antithrombin III, protein C, and protein S deficiencies. Chest 101(3), 816–823.
Fourrier F., Chopin C., Huart J., Runge I., Caron C., and Goudemand J. (1993) Double-blind, placebo-controlled trial of antithrombin III concentrates in septic shock with disseminated intravascular coagulation. Chest 104, 882–888.
Leclerc F., Hazelzet J. A., Jude B., Hofhuis W., Hue V., Martinot A., and van der Voort E. (1992) Protein C and S deficiency in severe infectious purpura of children: a collaborative study of 40 cases. Intensive Care Med. 18(4), 202–205.
Powars D. R., Rogers Z. R., Patch M. J., McGehee W. G., and Francis R. B. (1987) Purpura fulminans in meningococcemia: association with acquired deficiencies of protein C and S. N. Engl. J. Med. 317(9), 571–572.
Powars D., Larsen R., Johnson J., Hulbert T. Sun T., Patch M. J., Francis R., and Chan L. (1993) Epidemic meningococcemia and purpura fulminans with induced protein C deficiency. Clin. Infect. Dis. 17, 254–261.
Fijnvandraat K., Derkx B., Peters M., Bijlmer R., Sturk A., Prins M. H., et al. (1995) Coagulation activation and tissue necrosis in meningococcal septic shock: severely reduced protein C levels predict a high mortality. Thromb. Haemost. 73, 15–20.
Hazelzet J. A., Risseeuw-Appel I. M., Kornelisse R. F., Hop W. C. G., Dekker I., Joosten K. F. M., de Groot R., and Hack C. E. (1996) Age-related differences in outcome and severity of DIC in children with septic shock and purpura. Thromb. Haemost. 76(6), 932–938.
Brandtzaeg P., Joo G. B., Brusletto B., and Kierulf P. (1990) Plasminogen activator inhibitor 1 and 2, alpha-2-antiplasmin, plasminogen, and endotoxin levels in systemic meningococcal disease. Thromb. Res. 57(2), 271–278.
Kornelisse R. F., Hazelzet J. A., Savelkoul H. F. J., Hop W. C. J., Suur M. H., Borsboom A. N. J., Risseeuw-Appel I. M., v. d. Voort E., and d. Groot R. (1996) The relationship between plasminogen activator inhibitor-1 and proinflammatory and counterinflammatory mediators in children with meningococcal septic shock. J. Infect. Dis. 173, 1148–1156.
Voss R., Matthias R. R., Borkowski G., and Reitz D. (1990) Activation and inhibition of fibrinolysis in septic patients in an internal intensive care unit. Br. J. Haematol. 75, 99–105.
Philippe I, Offner F., Declerck P. J., Leroux-Roels G., Vogelaers D., Baele G., and Collen D. (1991) Fibrinolysis and coagulation in patients with infectious disease and sepsis. Thromb. Haemost. 65(3), 291–295.
Hesselvik J. F., Blombäck M., Brodin B., and Maller R. (1989) Coagulation, fibrinolysis, and kallikrein systems in sepsis: relation to outcome. Crit. Care Med. 17(8), 724–733.
Hermans P. W., Hibberd M. L., Booy R., Daramola O., Hazelzet J. A., de R. Groot, and Levin M. (1999) 4G/5G promoter polymorphism in the plasminogen-activator-inhibitor-1 gene and outcome of meningococcal disease. Meningococcal Research Group. Lancet 354(9178), 556–560.
Taylor F. (1994) The inflammatory-coagulant axis in the host response to gram-negative sepsis: regulatory roles of proteins and inhibitors of tissue factor. N. Horizons 2, 555–565.
Esmon C. T., Fukudome K., Mather T., Bode W., Regan L. M., Stearns-Kurosawa D. J., and Kurosawa S. (1999) Inflammation, sepsis, and coagulation. Haematologica 84(3), 254–259.
Cicala C. and G. Cirino (1998) Linkage between inflammation and coagulation: an update on the molecular basis of the crosstalk. Life Sci. 62(20), 1817–1824.
de Jonge E., Levi M., Stoutenbeek C. P., and van Deventer S. J. (1998) Current drug treatment strategies for disseminated intravascular coagulation. Drugs 55(6), 767–777.
de Jonge E., Dekkers P. E., Creasey A. A., Hack C. E., Paulson S. K., Karim A., et al. (2000) Tissue factor pathway inhibitor dose-dependently inhibits coagulation activation without influencing the fibrinolytic and cytokine response during human endotoxemia. Blood 95(4), 1124–1129.
McManus M. L. and Churchwell K. B. (1993) Coagulopathy as a predictor of outcome in meningococcal sepsis and the systemic inflammatory response syndrome with purpura. Crit. Care Med. 21, 706–711.
Vik-Mo H., Lote K., and Nordoy A. (1978) Disseminated intravascular coagulation in patients with meningococcal infection: laboratory diagnosis and prognostic factors. Scand. J. Infect. Dis. 10(3), 187–191.
Giraud T., Dhainaut J. F., Schremmer B., Regnier B., Desjars P., Loirat P., et al. (1991) Adult overwhelming meningococcal purpura. A study of 35 cases, 1977–1989. Arch. Intern. Med. 151(2), 310–31
Leclerc F., Beuscart R., Guillois B., Diependaele J. F., Krim G., Devictor D., Bompard Y., and van-Albada T. (1985) Prognostic factors of severe infectious purpura in children. Intensive Care Med. 11(3), 140–143.
Wuillemin W. A., Fijnvandraat K., Derkx B. H. F., Peters M., Vreede W., Cate H. T., and Hack C. (1995) Activation of the intrinsic pathway of coagulation in children with meningococcal septic shock. Thromb. Haemost. 74, 1436–1441.
Engebretsen L., Kierulf P., and Brandtzaeg P. (1986) Extreme plasminogen activator inhibitor and endotoxin values in patients with meningococcal disease. Thromb. Res. 42, 713–716.
Fijnvandraat K., Peters M., Derkx B., van Deventer S., and ten Cate J. W. (1994) Endotoxin induced coagulation activation and protein C reduction in meningococcal septic shock. Prog. Clin. Biol. Res. 388, 247–254.
Blanco A., Guisasola J. A., Solis P., Bachiller R., and Gonzalez H. (1990) Fibronectin in meningococcal sepsis. Correlation with antithrombin III and protein C. Acta Paediatr. Scand. 79(1), 73–76.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Humana Press Inc., Totowa, NJ
About this protocol
Cite this protocol
Hazelzet, J.A., Hack, C., de Groot, R. (2001). Coagulation Studies. In: Walker, J.M., Pollard, A.J., Maiden, M.C.J. (eds) Meningococcal Disease. Methods in Molecular Medicine™, vol 67. Humana Press. https://doi.org/10.1385/1-59259-149-3:513
Download citation
DOI: https://doi.org/10.1385/1-59259-149-3:513
Publisher Name: Humana Press
Print ISBN: 978-0-89603-849-3
Online ISBN: 978-1-59259-149-7
eBook Packages: Springer Protocols